Literature DB >> 12504112

The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein.

Polkit Sangvanich1, Bharti Mackness, Simon J Gaskell, Paul Durrington, Michael Mackness.   

Abstract

High-density lipoprotein (HDL) incubated with low-density lipoprotein (LDL) under oxidising conditions has previously been reported to decrease the accumulation of lipid peroxides on LDL and to diminish the biological effects of LDL, which would have been present had it been oxidatively modified in the absence of HDL. Thus far direct evidence that oxidative modification of LDL is diminished by HDL has, however, been lacking. We used electrospray ionisation mass spectrometry (ESI-MS) to detect 4-hydroxy-2-nonenal (HNE)-modified histidine residues of tryptic fragments of LDL which had been subject to Cu(2+) induced oxidation both in the presence and absence of human or avian HDL. HNE-modified angiotensin II was introduced into the incubation mixture as an internal standard and to check that HDL did not interfere in the detection of HNE-modified peptides non-specifically. Our results confirmed earlier reports that HNE modification of histidine occurs during the oxidation of LDL and for the first time revealed a marked attenuation of the process in the presence of human HDL with no effect on the detection of HNE-modified angiotensin II by ESI-MS. Avian HDL, which lacks the anti-oxidative enzyme paraoxonase, did not affect the formation of apo B adducts. Our findings therefore suggest that covalent linkage of lipid peroxidation products to LDL protein as well as the accumulation of lipid peroxides on LDL is diminished in the presence of HDL containing paraoxonase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12504112     DOI: 10.1016/s0006-291x(02)02849-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Conjugated linoleic acid isomers modulate protein expression profile in rat hepatocytes.

Authors:  E Rossi; L Della Casa; S Piana; A Iannone
Journal:  Genes Nutr       Date:  2012-05-05       Impact factor: 5.523

2.  Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.

Authors:  Robert L Wilensky; Yi Shi; Emile R Mohler; Damir Hamamdzic; Mark E Burgert; Jun Li; Anthony Postle; Robert S Fenning; James G Bollinger; Bryan E Hoffman; Daniel J Pelchovitz; Jisheng Yang; Rosanna C Mirabile; Christine L Webb; LeFeng Zhang; Ping Zhang; Michael H Gelb; Max C Walker; Andrew Zalewski; Colin H Macphee
Journal:  Nat Med       Date:  2008-09-21       Impact factor: 53.440

Review 3.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

Review 4.  Paraoxonase gene polymorphisms, oxidative stress, and diseases.

Authors:  Hong-Liang Li; De-Pei Liu; Chih-Chuan Liang
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

5.  Protective action of CLA against oxidative inactivation of paraoxonase 1, an antioxidant enzyme.

Authors:  Nguyen-Duy Su; Xi-Wen Liu; Mee Ree Kim; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2003-06       Impact factor: 1.880

6.  The protective effects of HDL and its constituents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL.

Authors:  Steffi Kopprasch; Jens Pietzsch; Juergen Graessler
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

7.  PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways.

Authors:  Jordi Camps; Anabel García-Heredia; Anna Rull; Carlos Alonso-Villaverde; Gerard Aragonès; Raúl Beltrán-Debón; Esther Rodríguez-Gallego; Jorge Joven
Journal:  PPAR Res       Date:  2012-01-24       Impact factor: 4.964

Review 8.  Lipoproteins as targets and markers of lipoxidation.

Authors:  Catarina B Afonso; Corinne M Spickett
Journal:  Redox Biol       Date:  2018-12-06       Impact factor: 11.799

9.  Reduced Antioxidant Potential of LDL Is Associated With Increased Susceptibility to LDL Peroxidation in Type II Diabetic Patients.

Authors:  Nivedita Singh; Neelima Singh; Sanjeev Kumar Singh; Ajay Kumar Singh; Deepak Kafle; Navneet Agrawal
Journal:  Int J Endocrinol Metab       Date:  2012-09-30

10.  Potential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal women.

Authors:  Joel Perrella; Mauricio Berco; Anthony Cecutti; Alan Gerulath; Bhagu R Bhavnani
Journal:  Lipids Health Dis       Date:  2003-06-20       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.